{"id":35108,"date":"2026-02-10T15:04:05","date_gmt":"2026-02-10T15:04:05","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/immune-checkpoint-inhibitors-market-mordor\/"},"modified":"2026-10-02T15:12:07","modified_gmt":"2026-10-02T06:12:07","slug":"immune-checkpoint-inhibitors-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/immune-checkpoint-inhibitors-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031\ub144)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immune-checkpoint-inhibitors-market_1662013864080_Immune_-_MP.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/immune-checkpoint-inhibitors-market-size-image-1768490460419.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 R&amp;D \ubc0f \uc784\uc0c1 \uc2dc\ud5d8 \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc81c\ud488 \uc2b9\uc778 \ubc0f \ud2b9\ubcc4 \uc9c0\uc815 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \ucd08\uae30 \ubc0f \ubcf4\uc870 \uc694\ubc95 \ud658\uacbd\uc73c\ub85c\uc758 ICI \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.4 AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac\uc73c\ub85c \ubc18\uc751\ub960 \ud5a5\uc0c1<\/li>\n<li class=\"toc-level-3\">4.2.5 \ud53c\ud558 ICI \uc81c\ud615\uc758 \uc131\uc7a5\uc73c\ub85c \uc8fc\uc785 \uc6a9\uc774\uc131 \uc99d\ub300<\/li>\n<li class=\"toc-level-3\">4.2.6 \uad6d\ub0b4 \uc0dd\uc0b0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uac00 \uac00\uaca9 \uacbd\uc7c1\ub825 \uc8fc\ub3c4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubcf4\ud5d8 \uc801\uc6a9 \uc7a5\ubcbd<\/li>\n<li class=\"toc-level-3\">4.3.2 \uba74\uc5ed \uad00\ub828 \uc774\uc0c1 \ubc18\uc751 \ubc0f \uc548\uc804\uc131 \ubb38\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.3 &#8216;\ucc28\uac00\uc6b4&#8217; \uc885\uc591\uc758 \uc801\uc751 \uc800\ud56d\uc73c\ub85c \uc9c0\uc18d\uc131 \uc81c\ud55c<\/li>\n<li class=\"toc-level-3\">4.3.4 ICI \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ucd9c\uc2dc\ub85c \uc778\ud55c \uac00\uaca9 \ud558\ub77d \ubc0f ROI \uac10\uc18c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.4.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.2 \uad6c\ub9e4\uc790\/\uc18c\ube44\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.3 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.4.4 \ub300\uccb4 \uc81c\ud488\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.4.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (USD \uac00\uce58)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc5b5\uc81c\uc81c \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 CTLA-4 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.2 PD-1 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.3 PD-L1 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.4 LAG-3 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.5 TIGIT \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.1.6 TIM-3 \ubc0f \uae30\ud0c0 \ucc28\uc138\ub300 \uccb4\ud06c\ud3ec\uc778\ud2b8<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uc801\uc751\uc99d\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \ube44\uc18c\uc138\ud3ec\ud3d0\uc554 (NSCLC)<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc18c\uc138\ud3ec\ud3d0\uc554 (SCLC)<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud751\uc0c9\uc885<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc2e0\uc138\ud3ec\uc554<\/li>\n<li class=\"toc-level-3\">5.2.5 \ub450\uacbd\ubd80\uc554<\/li>\n<li class=\"toc-level-3\">5.2.6 \uc694\ub85c\uc0c1\ud53c\uc554 \ubc0f \ubc29\uad11\uc554<\/li>\n<li class=\"toc-level-3\">5.2.7 \uac04\uc138\ud3ec\uc554<\/li>\n<li class=\"toc-level-3\">5.2.8 \ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885<\/li>\n<li class=\"toc-level-3\">5.2.9 \uae30\ud0c0 \uc554<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc815\ub9e5 \uc8fc\uc0ac<\/li>\n<li class=\"toc-level-3\">5.3.2 \ud53c\ud558 \uc8fc\uc0ac<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \uc720\ud1b5 \ucc44\ub110\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc18c\ub9e4 \uc57d\uad6d<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc628\ub77c\uc778 \uc57d\uad6d<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uae30\ud0c0 \uc720\ub7fd<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uae30\ud0c0 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uae30\ud0c0 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uae30\ud0c0 \ub0a8\ubbf8<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 Bristol-Myers Squibb<\/li>\n<li class=\"toc-level-3\">6.3.2 Merck &amp; Co.<\/li>\n<li class=\"toc-level-3\">6.3.3 F. Hoffmann-La Roche<\/li>\n<li class=\"toc-level-3\">6.3.4 Regeneron Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.5 AstraZeneca<\/li>\n<li class=\"toc-level-3\">6.3.6 Eli Lilly<\/li>\n<li class=\"toc-level-3\">6.3.7 Sanofi<\/li>\n<li class=\"toc-level-3\">6.3.8 BeiGene<\/li>\n<li class=\"toc-level-3\">6.3.9 Junshi Biosciences<\/li>\n<li class=\"toc-level-3\">6.3.10 GlaxoSmithKline<\/li>\n<li class=\"toc-level-3\">6.3.11 Innovent Biologics<\/li>\n<li class=\"toc-level-3\">6.3.12 Novartis<\/li>\n<li class=\"toc-level-3\">6.3.13 Incyte<\/li>\n<li class=\"toc-level-3\">6.3.14 Exelixis<\/li>\n<li class=\"toc-level-3\">6.3.15 Gilead Sciences<\/li>\n<li class=\"toc-level-3\">6.3.16 Ono Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.17 Zai Lab<\/li>\n<li class=\"toc-level-3\">6.3.18 Shanghai Henlius<\/li>\n<li class=\"toc-level-3\">6.3.19 Iovance Biotherapeutics<\/li>\n<li class=\"toc-level-3\">6.3.20 MacroGenics<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(Immune Checkpoint Inhibitors, ICIs) \uc2dc\uc7a5\uc740 2020\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0\uc758 \uc5f0\uad6c \uae30\uac04 \ub3d9\uc548 \uc0c1\ub2f9\ud55c \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. 2025\ub144 502.9\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2026\ub144 584.3\uc5b5 \ub2ec\ub7ec\ub85c \uc131\uc7a5\ud55c \ud6c4, 2031\ub144\uc5d0\ub294 1,235.7\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR)\uc740 16.18%\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc608\uce21\ub429\ub2c8\ub2e4. \ubd81\ubbf8 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc73c\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud604\uc7ac \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc774 \uc2dc\uc7a5\uc740 \uc5b5\uc81c\uc81c \uc720\ud615(CTLA-4 \uc5b5\uc81c\uc81c, PD-1 \uc5b5\uc81c\uc81c \ub4f1), \uc801\uc751\uc99d(\ube44\uc18c\uc138\ud3ec\ud3d0\uc554 \ub4f1), \ud22c\uc5ec \uacbd\ub85c(\uc815\ub9e5 \uc8fc\uc0ac \ubc0f \ud53c\ud558 \uc8fc\uc0ac), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d \ub4f1), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc138\ubd84\ud654\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uc608\uce21\uc740 \uac00\uce58(USD) \uae30\uc900\uc73c\ub85c \uc81c\uacf5\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778 \ubc0f \uc81c\uc57d \uc694\uc778<\/p>\n<p>\uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc740 \uc5ec\ub7ec \ud575\uc2ec \ub3d9\uc778\uc5d0 \uc758\ud574 \ucd09\uc9c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \ub3d9\uc778\uc73c\ub85c\ub294 \uaddc\uc81c \uc2b9\uc778 \ud655\ub300 \ubc0f \ud2b9\ubcc4 \uc9c0\uc815(\uc608: FDA\uc758 \ub808\ud2f0\ud310\ub9ac\ub9d9-dlwr \ubc0f \ucf54\uc2dc\ubca8\ub9ac\ub9d9-ipdl \uc2b9\uc778, EMA\uc758 \ud2f0\uc2ac\ub810\ub9ac\uc8fc\ub9d9 \ubc0f \ub2c8\ubcfc\ub8e8\ub9d9-\uc774\ud544\ub9ac\ubb34\ub9d9 \uc801\uc751\uc99d \ud655\ub300), \ubcd1\uc6a9 \uc694\ubc95\uc758 \ube60\ub978 \ucc44\ud0dd, LAG-3, TIGIT, TIM-3\uc640 \uac19\uc740 \ucc28\uc138\ub300 \ud45c\uc801 \uac1c\ubc1c, \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc758 \ud655\uc0b0, \uc778\uacf5\uc9c0\ub2a5(AI) \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uad74(\uc608: AI \uac15\ud654 PD-L1 SP263 \ubd84\uc11d\ubc95), \uc218\uc220 \uc804\ud6c4 \ubcf4\uc870 \uc694\ubc95\uc73c\ub85c\uc758 \uc801\uc6a9 \ubc94\uc704 \ud655\uc7a5, R&#038;D \ubc0f \uc784\uc0c1 \uc2dc\ud5d8 \ud22c\uc790 \uc99d\uac00(\uc608: \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045\uc758 \uba74\uc5ed\ud56d\uc554 \ud504\ub85c\uadf8\ub7a8 \ub9e4\ucd9c \uc99d\uac00, \ub178\ubc14\ud2f0\uc2a4\uc758 \uc778\uc218 \ud22c\uc790), M&#038;A \ud65c\ub3d9 \uc99d\uac00(\uc608: \uc120 \ud30c\ub9c8\uc288\ud2f0\uceec\uc758 \uccb4\ud06c\ud3ec\uc778\ud2b8 \ud14c\ub77c\ud4e8\ud2f1\uc2a4 \uc778\uc218), \uc544\uc2dc\uc544 \uc2dc\uc7a5\uc758 \ube60\ub978 \uc131\uc7a5, \uadf8\ub9ac\uace0 \uad6d\ub0b4 \uc0dd\uc0b0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uc131\uc7a5\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\ub4e4\ub3c4 \uc874\uc7ac\ud569\ub2c8\ub2e4. \ub192\uc740 \uce58\ub8cc \ube44\uc6a9 \ubc0f \ubcf4\ud5d8 \uc801\uc6a9 \ubb38\uc81c(\uc608: \ubbf8\uad6d \ub0b4 \uc6d4\ubcc4 \uce58\ub8cc \ube44\uc6a9 \ubd80\ub2f4, \uc778\ud50c\ub808\uc774\uc158 \uac10\ucd95\ubc95\uc73c\ub85c \uc778\ud55c \uc0c1\ud658 \uc555\ubc15), \uba74\uc5ed \uad00\ub828 \ubd80\uc791\uc6a9, &#8216;\ucc28\uac00\uc6b4 \uc885\uc591&#8217;\uc5d0\uc11c\uc758 \uc801\uc751\uc131 \uc800\ud56d(\uc608: STK11, KEAP1, JAK \ub3cc\uc5f0\ubcc0\uc774\ub85c \uc778\ud55c \uba74\uc5ed \uce68\ud22c \ubc29\ud574), \uadf8\ub9ac\uace0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ub85c \uc778\ud55c \uac00\uaca9 \ud558\ub77d(\ud2b9\ud788 \ubd81\ubbf8 \ubc0f \uc720\ub7fd \uc2dc\uc7a5) \ub4f1\uc774 \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>*   \uc5b5\uc81c\uc81c \uc720\ud615\ubcc4: PD-1 \uc81c\uc81c\uac00 2025\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 60.92%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4(\ud0a4\ud2b8\ub8e8\ub2e4, \uc635\ub514\ubcf4). LAG-3 \ubd84\uc790\ub294 2031\ub144\uae4c\uc9c0 17.49%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uba5c\ub77c\ub178\ub9c8 \uce58\ub8cc\uc5d0\uc11c\uc758 \ucc44\ud0dd\uc774 \uc774\ub97c \ub4b7\ubc1b\uce68\ud569\ub2c8\ub2e4. PD-L1 \uc81c\ud488\uc740 \uc870\uc9c1 \ubd88\ubb38 \uc801\uc751\uc99d \ud655\ub300\ub85c \uc774\uc810\uc744 \uc5bb\uace0 \uc788\uc73c\uba70, CTLA-4 \uc5b5\uc81c\uc81c\ub294 \ubcd1\uc6a9 \uc694\ubc95\uc758 \ud30c\ud2b8\ub108 \uc5ed\ud560\ub85c \uc804\ud658\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. PD-1\uacfc LAG-3 \ub610\ub294 VEGF \ud45c\uc801\uc744 \uc5f0\uacb0\ud558\ub294 \uc774\uc911\ud2b9\uc774\uc131 \ud56d\uccb4\ub294 \ub2e8\uc77c \uc694\ubc95\uc758 \ud55c\uacc4\ub97c \uadf9\ubcf5\ud558\uace0 \uc9c0\uc801 \uc7ac\uc0b0\uad8c \uc218\uba85\uc744 \uc5f0\uc7a5\ud560 \uc7a0\uc7ac\ub825\uc744 \uac00\uc9d1\ub2c8\ub2e4.<br \/>\n*   \uc801\uc751\uc99d\ubcc4: \ube44\uc18c\uc138\ud3ec\ud3d0\uc554(NSCLC)\uc740 2025\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 26.34%\ub97c \ucc28\uc9c0\ud558\uba70 1\ucc28 \uce58\ub8cc\uc81c\ub85c\uc11c\uc758 \uc9c0\ubc30\ub825\uc744 \uc720\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc18c\uc138\ud3ec\ud3d0\uc554(SCLC)\uc740 2031\ub144\uae4c\uc9c0 22.55%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub978 \uc131\uc7a5\uc744 \ubcf4\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uba5c\ub77c\ub178\ub9c8\ub294 LAG-3 \ubcd1\uc6a9 \uc2b9\uc778\uc744 \ud1b5\ud574 \uafb8\uc900\ud55c \ucc44\ud0dd\uc744 \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, \uc2e0\uc7a5\uc554(RCC) \ubc0f \uac04\uc138\ud3ec\uc554(HCC)\uc740 \uba74\uc5ed\ud56d\uc554\uc81c-VEGF \ubcd1\uc6a9 \uc694\ubc95\uc5d0 \uc798 \ubc18\uc751\ud569\ub2c8\ub2e4. \uc694\ub85c\uc0c1\ud53c\uc554\uc740 \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC) \uc2dc\ub108\uc9c0\ub97c \ud65c\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \uc815\ub9e5 \uc8fc\uc0ac(IV)\ub294 2025\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 67.95%\ub97c \ucc28\uc9c0\ud558\uba70, \ud655\ub9bd\ub41c \ud504\ub85c\ud1a0\ucf5c\uacfc \ubcf4\ud5d8 \uc801\uc6a9\uc758 \uc775\uc219\ud568\uc73c\ub85c \uc120\ud638\ub429\ub2c8\ub2e4. \ud53c\ud558 \uc8fc\uc0ac(SC) \uc81c\ud615\uc740 2031\ub144\uae4c\uc9c0 25.4%\uc758 CAGR\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \ud658\uc790 \ud3b8\uc758\uc131 \uc99d\ub300 \ubc0f \uc758\ub8cc \uc778\ud504\ub77c \ubd80\ub2f4 \uacbd\uac10\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4.<br \/>\n*   \uc720\ud1b5 \ucc44\ub110\ubcc4: \ubcd1\uc6d0 \uc57d\uad6d\uc740 2025\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 56.88%\ub97c \ucc28\uc9c0\ud558\uba70, \uba74\ubc00\ud55c \ubaa8\ub2c8\ud130\ub9c1 \ud544\uc694\uc131\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uc628\ub77c\uc778 \uc57d\uad6d\uc740 \ucf5c\ub4dc\uccb4\uc778 \ubb3c\ub958\uc758 \uc131\uc219\uacfc \uc6d0\uaca9 \uc885\uc591\ud559(tele-oncology) \ucc44\ud0dd\uc5d0 \ud798\uc785\uc5b4 19.95%\uc758 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\ub294 2025\ub144 \uc2dc\uc7a5 \ub9e4\ucd9c\uc758 36.74%\ub97c \ucc28\uc9c0\ud558\uba70, \uc720\ub9ac\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uacfc \ub192\uc740 \uc784\uc0c1 \uc2dc\ud5d8 \ubc00\ub3c4\uc5d0 \ud798\uc785\uc5b4 \uac00\uc7a5 \ud070 \uc2dc\uc7a5\uc785\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uaddc\uc81c \uc870\ud654 \ubc0f \ud604\uc9c0 \uc0dd\uc0b0 \uc778\uc13c\ud2f0\ube0c\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 19.56%\uc758 CAGR\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc720\ub7fd\uc740 \uc870\ud654\ub85c\uc6b4 \uaddc\uc81c \uacbd\ub85c\uc640 \uac00\uce58 \uae30\ubc18 \uc758\ub8cc \ucc44\ud0dd\uc744 \ud1b5\ud574 \uafb8\uc900\ud55c \uc131\uc7a5\uc744 \ubcf4\uc785\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubc0f \ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5<\/p>\n<p>\uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 \ub2e4\uad6d\uc801 \uae30\uc5c5\uacfc \ubca4\ucc98 \uc9c0\uc6d0 \ub3c4\uc804\uc790\ub4e4 \uac04\uc758 \uce58\uc5f4\ud55c \uacbd\uc7c1 \uc18d\uc5d0\uc11c \uc911\uac04 \uc815\ub3c4\uc758 \uc9d1\uc911\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \uba38\ud06c(Merck)\uc758 \ud0a4\ud2b8\ub8e8\ub2e4(Keytruda)\ub294 2025\ub144 222\uc5b5 \ub2ec\ub7ec\uc758 \ub9e4\ucd9c\uc744 \ubaa9\ud45c\ub85c \ud558\uace0 \uc788\uc73c\uba70, \ube0c\ub9ac\uc2a4\ud1a8 \ub9c8\uc774\uc5b4\uc2a4 \uc2a4\ud045(Bristol Myers Squibb)\uc758 \uc635\ub514\ubcf4(Opdivo) \ud504\ub79c\ucc28\uc774\uc988\ub3c4 \uac15\ub825\ud55c \uc2dc\uc7a5 \uc9c0\uc704\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc740 \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615 \uac1c\ubc1c, \uc0c8\ub85c\uc6b4 \ubcd1\uc6a9 \uc694\ubc95, \ubc14\uc774\uc624\ub9c8\ucee4 \ud30c\ud2b8\ub108\uc2ed\uc744 \ud1b5\ud574 \uc81c\ud488 \uc218\uba85 \uc8fc\uae30\ub97c \uc5f0\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc120 \ud30c\ub9c8\uc288\ud2f0\uceec\uc758 \uccb4\ud06c\ud3ec\uc778\ud2b8 \ud14c\ub77c\ud4e8\ud2f1\uc2a4 \uc778\uc218\uc640 \uac19\uc740 M&#038;A \ud65c\ub3d9\uc740 \ud601\uc2e0\uc801\uc778 \uc790\uc0b0 \ud655\ubcf4\ub97c \uc704\ud55c \uc804\ub7b5\uc801 \uc6c0\uc9c1\uc784\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>\uc774\uc911\ud2b9\uc774\uc131 \ud504\ub85c\uadf8\ub7a8(\uc608: BNT327, \uc774\ubcf4\ub124\uc2dc\ub9d9)\uc758 \ubc1c\uc804\uacfc AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \uae30\uc5c5\uc758 \ub4f1\uc7a5\uc740 \uc815\ubc00 \uc758\ud559 \uc2dc\ub300\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc544\uc2dc\uc544 \uc2dc\uc7a5\uc758 \ubc14\uc774\uc624\uc544\uc2dc\uc544 \uc2dc\uc7a5\uc758 \ubc14\uc774\uc624 \uae30\uc5c5\ub4e4\uc740 \uc790\uccb4\uc801\uc778 \ud601\uc2e0 \uc5ed\ub7c9\uc744 \uac15\ud654\ud558\uba70 \uae00\ub85c\ubc8c \uacbd\uc7c1\uc5d0 \ucc38\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \uc911\uad6d\uacfc \ud55c\uad6d\uc740 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ubc0f \uc2e0\uc57d \uac1c\ubc1c\uc5d0 \uc801\uadf9\uc801\uc73c\ub85c \ud22c\uc790\ud558\uba70 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ud50c\ub808\uc774\uc5b4\ub85c \ubd80\uc0c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc5ed\ub3d9\uc801\uc778 \ud658\uacbd\uc740 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc758 \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uacfc \ud601\uc2e0\uc744 \ucd09\uc9c4\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc774 \ubcf4\uace0\uc11c\ub294 \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c(Immune Checkpoint Inhibitors, ICI) \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc5f0\uad6c\ub294 PD-1, PD-L1, CTLA-4, LAG-3, TIGIT, TIM-3 \ubc0f \uae30\ud0c0 \ucc28\uc138\ub300 \ud45c\uc801\uc744 \ucc28\ub2e8\ud558\ub294 \ucc98\ubc29 \ub4f1\uae09 \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\ub85c\ubd80\ud130 \ubc1c\uc0dd\ud558\ub294 \uc804 \uc138\uacc4 \ub9e4\ucd9c\uc744 \ub300\uc0c1\uc73c\ub85c \ud558\uba70, \ubaa8\ub4e0 \uce58\ub8cc \ub2e8\uacc4\uc758 \uc885\uc591\ud559 \uc801\uc751\uc99d\uc5d0 \uc0ac\uc6a9\ub418\ub294 \uc81c\ud488\uc744 \ud3ec\ud568\ud569\ub2c8\ub2e4. \ub3d9\ubc18 \uc9c4\ub2e8, \uc774\uc911\ud2b9\uc774\uc131 \ub610\ub294 CAR-T \uad6c\uc131, \uad11\ubc94\uc704\ud55c \uba74\uc5ed\uce58\ub8cc\uc81c \ud074\ub798\uc2a4\uc5d0 \uc18d\ud558\ub294 \ub9e4\ucd9c\uc740 \uc81c\uc678\ub429\ub2c8\ub2e4. \uc2dc\uc7a5 \uac00\uce58\ub294 2025\ub144 \ubd88\ubcc0 USD \uae30\uc900\uc758 \uacf5\uc7a5 \ucd9c\ud558\uac00(ex-factory sales)\ub97c \ubc18\uc601\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\uc5d0 \ub530\ub974\uba74, \uba74\uc5ed\uad00\ubb38\uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc740 2026\ub144 584\uc5b5 3\ucc9c\ub9cc \ub2ec\ub7ec \uaddc\ubaa8\uc774\uba70, 2031\ub144\uae4c\uc9c0 \ub450 \ubc30 \uc774\uc0c1 \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc5f0\uad6c \uac1c\ubc1c \ubc0f \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00, \uc81c\ud488 \uc2b9\uc778 \ubc0f \ud2b9\ubcc4 \uc9c0\uc815 \ud655\ub300, ICI\uc758 \ucd08\uae30 \uce58\ub8cc \ubc0f \ubcf4\uc870 \uc694\ubc95\uc73c\ub85c\uc758 \ud655\uc7a5, AI \uae30\ubc18 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac\uc744 \ud1b5\ud55c \ubc18\uc751\ub960 \ud5a5\uc0c1, \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc758 \uc131\uc7a5\uc73c\ub85c \uc778\ud55c \uc8fc\uc785 \uc6a9\ub7c9 \ubd80\ub2f4 \uc644\ud654, \uadf8\ub9ac\uace0 \ud604\uc9c0 \uc0dd\uc0b0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \ubcf4\uae09\uc744 \ud1b5\ud55c \uc811\uadfc\uc131 \ubc0f \uacbd\uc81c\uc131 \uc99d\uc9c4 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc2dc\uc7a5\uc758 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \ub192\uc740 \uce58\ub8cc \ube44\uc6a9\uacfc \ubcf4\ud5d8 \uc0c1\ud658\uc758 \uc5b4\ub824\uc6c0, \uba74\uc5ed \uad00\ub828 \uc774\uc0c1 \ubc18\uc751 \ubc0f \uc548\uc804\uc131 \ubb38\uc81c, &#8220;\ucc28\uac00\uc6b4&#8221; \uc885\uc591\uc5d0\uc11c\uc758 \uc801\uc751\uc131 \ub0b4\uc131\uc73c\ub85c \uc778\ud55c \uce58\ub8cc \uc9c0\uc18d\uc131 \ud55c\uacc4, \uadf8\ub9ac\uace0 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ucd9c\uc2dc\ub85c \uc778\ud55c \uac00\uaca9 \ud558\ub77d \ubc0f \ud22c\uc790 \uc218\uc775\ub960(ROI) \uac10\uc18c \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21\uc740 \uc5b5\uc81c\uc81c \uc720\ud615(CTLA-4, PD-1, PD-L1, LAG-3, TIGIT, TIM-3 \ubc0f \uae30\ud0c0 \ucc28\uc138\ub300 \uccb4\ud06c\ud3ec\uc778\ud2b8), \uc801\uc751\uc99d(\ube44\uc18c\uc138\ud3ec\ud3d0\uc554, \uc18c\uc138\ud3ec\ud3d0\uc554, \ud751\uc0c9\uc885, \uc2e0\uc7a5\uc554, \ub450\uacbd\ubd80\uc554, \uc694\ub85c\uc0c1\ud53c\uc554 \ubc0f \ubc29\uad11\uc554, \uac04\uc138\ud3ec\uc554, \ud638\uc9c0\ud0a8 \ub9bc\ud504\uc885 \ub4f1), \ud22c\uc5ec \uacbd\ub85c(\uc815\ub9e5 \uc8fc\uc0ac, \ud53c\ud558 \uc8fc\uc0ac), \uc720\ud1b5 \ucc44\ub110(\ubcd1\uc6d0 \uc57d\uad6d, \uc18c\ub9e4 \uc57d\uad6d, \uc628\ub77c\uc778 \uc57d\uad6d), \uadf8\ub9ac\uace0 \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8)\ubcc4\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ub429\ub2c8\ub2e4.<\/p>\n<p>\ud2b9\ud788, PD-1 \uc5b5\uc81c\uc81c\uac00 Keytruda\uc640 Opdivo\ub97c \uc911\uc2ec\uc73c\ub85c \uc804\uccb4 \ub9e4\ucd9c\uc758 60.92%\ub97c \ucc28\uc9c0\ud558\uba70 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ubcf4\uc785\ub2c8\ub2e4. \uc18c\uc138\ud3ec\ud3d0\uc554(SCLC)\uc740 \uc81c\ud55c\uc801\uc778 \uae30\uc874 \uce58\ub8cc \uc635\uc158\uacfc \uc0c8\ub85c\uc6b4 \ubcd1\uc6a9 \uc694\ubc95 \uc2b9\uc778\uc5d0 \ud798\uc785\uc5b4 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 22.55%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc554 \uc720\ud615\uc73c\ub85c \ub098\ud0c0\ub0ac\uc2b5\ub2c8\ub2e4. \ud53c\ud558 \uc8fc\uc0ac \uc81c\ud615\uc740 \ud22c\uc5ec \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uc8fc\uc785 \uc6a9\ub7c9 \uc81c\uc57d\uc744 \uc644\ud654\ud558\uba70 \uc678\ub798 \uce58\ub8cc \ubaa8\ub378\uc744 \uc9c0\uc6d0\ud558\ub294 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728, \uadf8\ub9ac\uace0 Bristol-Myers Squibb, Merck &#038; Co., F. Hoffmann-La Roche, AstraZeneca \ub4f1 \uc8fc\uc694 20\uac1c \uae30\uc5c5\uc758 \ud504\ub85c\ud544\uc774 \ub2e4\ub8e8\uc5b4\uc9d1\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \ub610\ud55c \uc2dc\uc7a5 \uae30\ud68c\uc640 \ubbf8\ub798 \uc804\ub9dd\uc744 \uc81c\uc2dc\ud558\uba70, AI\uac00 \ubc14\uc774\uc624\ub9c8\ucee4 \ubc1c\uacac \ubc0f \ud658\uc790 \uacc4\uce35\ud654\ub97c \ud5a5\uc0c1\uc2dc\ucf1c \ucc28\uc138\ub300 \uc5b5\uc81c\uc81c\uc758 \ubc18\uc751\ub960\uc744 \ub192\uc774\uace0 \ud6c4\uae30 \uc784\uc0c1 \uc2dc\ud5d8 \uc2e4\ud328\uc728\uc744 \ub0ae\ucd94\ub294 \ub370 \uae30\uc5ec\ud55c\ub2e4\uace0 \uac15\uc870\ud569\ub2c8\ub2e4. \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \ub4f1\uc7a5\uc740 \ucc38\uc870 \uc81c\ud488\uc758 \uac00\uaca9\uc744 5\ub144 \uc774\ub0b4\uc5d0 30% \uc774\uc0c1 \uc778\ud558\ud558\uc5ec \ub9c8\uc9c4\uc5d0 \uc555\ub825\uc744 \uac00\ud558\uace0 \uac00\uce58 \uae30\ubc18 \uacc4\uc57d\uc73c\ub85c\uc758 \uc804\ud658\uc744 \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\uc758 \uc5f0\uad6c \ubc29\ubc95\ub860\uc740 \uc2e4\ubb34 \uc885\uc591 \uc804\ubb38\uc758, \ubcd1\uc6d0 \uc870\ub2ec \ucc45\uc784\uc790, \uc9c0\uc5ed\ubcc4 \ubcf4\ud5d8 \uc0c1\ud658 \uc804\ubb38\uac00\uc640\uc758 \uc2ec\uce35 \uc778\ud130\ubdf0\ub97c \ud3ec\ud568\ud558\ub294 1\ucc28 \uc5f0\uad6c\uc640 WHO GLOBOCAN, FDA, EMA, ClinicalTrials.gov \ub4f1\uc758 \uacf5\uac1c \uc18c\uc2a4\ub97c \ud65c\uc6a9\ud55c 2\ucc28 \uc5f0\uad6c\ub97c \uacb0\ud569\ud558\uc5ec \uc2e0\ub8b0\uc131\uc744 \ud655\ubcf4\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uaddc\ubaa8 \uc0b0\uc815 \ubc0f \uc608\uce21\uc740 \uc0c1\ud5a5\uc2dd \ubc0f \ud558\ud5a5\uc2dd \uc811\uadfc \ubc29\uc2dd\uc744 \ubaa8\ub450 \uc0ac\uc6a9\ud558\uc5ec \uac80\uc99d\ub418\uc5c8\uc73c\uba70, \uc8fc\uc694 \ubcc0\uc218\uc640 \uc2dc\ub098\ub9ac\uc624 \ubd84\uc11d\uc744 \ud1b5\ud574 2025-2030\ub144 \uc608\uce21\uc744 \ub3c4\ucd9c\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ud22c\uba85\ud55c \ubcc0\uc218, \uc2dc\uae30\uc801\uc808\ud55c \uc5c5\ub370\uc774\ud2b8, \ub2e4\uce35\uc801 \uac80\uc99d \uacfc\uc815\uc744 \ud1b5\ud574 Mordor Intelligence\uc758 \uc2dc\uc7a5 \uae30\uc900\uc120\uc740 \uc804\ub7b5 \uacc4\ud68d \uc218\ub9bd\uc744 \uc704\ud55c \uc2e0\ub8b0\ud560 \uc218 \uc788\ub294 \ucd9c\ubc1c\uc810\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-35108","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35108"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=35108"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/35108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=35108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=35108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=35108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}